Pharmafile Logo
Pharmafocus logo
Advanced Search

Novartis’ 2012 results flat

January 24, 2013
Sales and Marketing Bexsero, Jakavi, Novartis, generics, results

Generic competition has put a dent in Novartis’ financial results for 2012, with net sales down 3% year on year …

News
Novo Nordisk image

EU approval for Novo Nordisk diabetes drugs

January 24, 2013
Sales and Marketing Novo Nordisk, Ryzodeg, Tresiba

Novo Nordisk is celebrating after European regulators approved two of its drugs for the treatment of adults with diabetes. The …

News

Jörg Reinhardt to leave Bayer for Novartis

January 24, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, Novartis, Reinhardt

The chairman of the Board and member of the Bayer executive council Dr Jörg Reinhard is stepping down from his …

Appointment
Watson image

Watson buys women’s health specialists

January 23, 2013
Research and Development, Sales and Marketing Actavis, Uteron, Watson, women

Watson has completed the acquisition of Uteron Pharma, a Belgium R&D-based firm specialising in women’s health products. The world’s third-largest …

News
novartis image

EU approval for meningitis vaccine

January 23, 2013
Sales and Marketing Bexsero, CHMP, Novartis, meningitis

European regulators have approved Novartis’ Bexsero, making it the first broad coverage vaccine to target the leading cause of meningitis. …

News

New drug discovery alliance launches

January 23, 2013
Research and Development, Sales and Marketing CDRD, LDC, translational research

Six of the world’s top health science centres have banded together in an attempt to speed up the rate at …

News
john_reed

Roche adds head to corporate executive committee

January 23, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing John Reed, Roche

Roche has announced that John Reed has been appointed as head of Roche Pharma Research and Early Development (pRED) and …

Appointment
Ark Therapeutics image

Ark Therapeutics mulling fundraising options

January 22, 2013
Manufacturing and Production Ark Therapeutics

Contract development and manufacturing services company Ark Therapeutics has been forced to abandon proposals to raise money via an equity …

News
FDA image

Germany’s Hameln warned by FDA over GMP failings

January 22, 2013
Manufacturing and Production FDA, GMP, Hameln

German contract manufacturer Hameln Pharmaceuticals was sent a warning letter by the FDA last month detailing a number of Good …

News
Allergan image

Botox US bladder indication

January 22, 2013
Sales and Marketing Allergan, Botox, FDA, bladder

Allergan’s Botox has been given approval by the FDA for the treatment of overactive bladder (OAB) in adults.Botox (onabotulinumtoxinA) has …

News

Lundbeck sells $100m portfolio

January 22, 2013
Sales and Marketing Lundbeck, OTC, Panhematin, Recordati

Italian pharma group Recordati has paid $80 million to Lundbeck for a portfolio of products primarily aimed at the US …

News
karl_hamer

New appointment and promotions at Events 4 Healthcare

January 22, 2013
Medical Communications, Sales and Marketing Events 4 Healthcare

Comms agency Events 4 Healthcare has announced two new promotions and a new appointment to further enhance its team. Nicola …

Appointment
Novartis image

Novartis eye drug nears approval

January 21, 2013
Sales and Marketing AMD, CHMP, Jetria, Novartis

Novartis’ eye drug Jetrea has been given a positive opinion by the CHMP, pushing it to the brink of approval. …

News

CHMP nod for Pfizer CML drug

January 21, 2013
Sales and Marketing CHMP, CML, FDA, Pfizer

Pfizer’s cancer drug bosutinib has been given a positive opinion by the CHMP for patients with chronic myelogenous leukemia (CML). …

News

Crohn’s and Colitis UK hire new chief executive

January 21, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Crohn's and Colitis, David Barker

The medical charity Crohn’s and Colitis UK Trustees have announced the appointment of David Barker as the new chief executive …

Appointment
Lilly image

EU nod for Lilly brain diagnostic

January 18, 2013
Research and Development, Sales and Marketing Alzhheimer's, Amyvid, brain, lilly

Eli Lilly’s diagnostic radiopharmaceutical Amyvid has been approved in Europe to assess whether patients have Alzheimer’s disease. Amyvid (Florbetapir F …

News
ec-burgess_1000px

Roche’s Burgess to head up discovery at BMS

January 18, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMS, Burgess

Bristol-Myers Squibb has appointed Mike Burgess as senior vice president, Discovery Medicine and Clinical Pharmacology. He will report to Francis …

Appointment
Amgen image

Amgen earmarks $200m for new Singapore plant

January 18, 2013
Manufacturing and Production Amgen, Merck, Singapore

Amgen has unveiled plans to construct a new manufacturing plant in Singapore, its first production facility in Asia. The biotechnology …

News
Tysabri image

Biogen and Elan file for Tysabri first line use in MS

January 18, 2013
Sales and Marketing Biogen IDEC, EMA, Elan, FDA, MS, Tsyabri, gilenya

Biogen Idec and Elan have applied to the FDA and EMA to expand Tysabri’s use in patients with relapsing forms …

News

MPs: ‘get on with VBP’

January 18, 2013
Medical Communications, Sales and Marketing NHS, NICE, PPRS, VBP

An influential group of MPs has hit out at inactivity over moves towards value-based pricing (VBP), saying that the issue …

News
The Gateway to Local Adoption Series

Latest content

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026

Alvotech appoints Lisa Graver as CEO

February 3, 2026

HonorHealth Research Institute announces first patient dosed with new stroke treatment

February 2, 2026

Accord Healthcare appoints Paul Burden as Associate Vice President and Country Head UK

February 2, 2026

Historic UN declaration supporting mental health – treatment to be given similar priority to chronic diseases

January 30, 2026